| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 107,954 | 95,267 | 99,772 | 138,939 | | Cost of Revenue | 79,329 | 71,526 | 76,862 | 87,381 | | | Gross Profit | 28,625 | 23,741 | 22,910 | 51,558 | | | Operating Expenses | | Research Development | 2,862 | 3,178 | 3,472 | 3,803 | | Selling General and Administrative | 16,742 | 17,285 | 16,797 | 14,946 | | Non Recurring | 88 | 15,675 |
-
| 41 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,933 | (12,397) | 2,641 | 32,768 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,049) | 559 | 621 | (1,236) | | Earnings Before Interest And Taxes | 7,884 | (11,838) | 3,262 | 31,532 | | Interest Expense | 1,520 | 1,864 | 2,085 | 1,025 | | Income Before Tax | 6,364 | (13,702) | 1,177 | 30,507 | | Income Tax Expense | 1,428 | (2,492) | 469 | 9,254 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,936 | (11,210) | 708 | 21,253 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,936 | (11,210) | 708 | 21,253 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,936 | ($11,210) | $708 | $21,253 |
|
0.75% Nasdaq 
Income Statement
